Recent News

• 05.13.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
• 05.13.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
• 05.01.2025 - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
• 05.01.2025 - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
• 04.25.2025 - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
• 04.25.2025 - Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
• 03.31.2025 - Repare Therapeutics Announces Leadership Transitions
• 03.31.2025 - Repare Therapeutics Announces Leadership Transitions

Recent Filings

• 05.01.2025 - 8-K Current report
• 05.01.2025 - EX-99.1 EX-99.1
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - 3 Initial statement of beneficial ownership of securities
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1